Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 51

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 51
---
 affect our business, financial condition, results of operations, and stock price, and our stockholders would be exposed to additional risks, including:

| • |     | to the extent the current market price of our stock reflects an assumption that the Divestiture will be 
 completed, the market price of our common stock could decrease if the Divestiture is not completed;     |

| • |     | investor confidence in us could decline, stockholder litigation could be brought against us, relationships with 
 existing and prospective customers, service providers, investors, lenders and other                             |

- 34 -

| business partners may be adversely impacted, we may be unable to retain key personnel, and our operating results may be adversely impacted due to costs incurred in connection with the 
 Divestiture;                                                                                                                                                                            |

| • |     | any disruptions to our business resulting from the announcement and pendency of the Divestiture could adversely                                                                                                                                    
 affect our customer and partner relationships, including with respect to concerns about possible changes to our products and or policies, and current or future business relationships with us, may cause customers to refrain from purchasing our 
 products, and may cause partners to seek a change to existing business relationships;                                                                                                                                                              |

| • |     | the risks related to the diversion of attention of our management or employees, the uncertainty our employees may                                                                                                                                        
 have about their roles upon consummation of the Divestiture, and the ability for us to attract and retain key talent, including senior leaders, to the same extent that we have previously been able to attract and retain employees during the pendency 
 of the Divestiture; and                                                                                                                                                                                                                                  |

| • |     | the requirement that we pay a termination fee under certain circumstances that give rise to the termination of 
 the Divestiture Agreement.                                                                                     |

There can be no assurance that our business, relationships with other parties, liquidity or our financial condition will not be adversely affected, as compared to the condition prior to the announcement of the Divestiture if the Divestiture is not consummated. Even if successfully completed, there are certain risks to our stockholders from the Divestiture, including:

| • |     | we may experience a departure of employees, prior to the closing of the Divestiture; |

| • |     | the amount of cash to be paid under the Divestiture Agreement is fixed and will not be adjusted for changes in                                                                                          
 our business, prospects, outlook, financial condition or operating results or in the event of any change in the market price